接收到L-Cyclopropylglycine ≥99%产品后,置于4°C温度下保存。 其他 Usbiological公司是美国著名的抗体和生化试剂供应商,生产世界上种类最多的抗体,用于Western Blot、免疫沉淀、免疫荧光、免疫组化和流式细胞术等多种检测方法。Usbiological公司现已拥有超过50,19234种抗体、抗原和生化产品,为科研用户提供了诸多超值...
中文名称:Boc-L-Cyclopropylglycine CAS号:155976-13-9 缩写:Boc-L-Cyclopropylglycine 英文名称:Boc-L-Cyclopropylglycine 纯度:>98% 包装1:1g 价格1:请联系客服询价 包装2:5g 价格2:请联系客户询价 上一个:Boc-Leu-chloromethylketone 下一个:BOC-L-Cyclopropylalanine ...
Product Name: BOC-L-cyclopropylglycine Synonyms: CAS: MF: C10H17NO4 MW: 215.24628 EINECS: Mol File: Mol FileInformation Error Report Your Email: Browse by Nationality BOC-L-cyclopropylglycine Suppliers China suppliers BOC-L-cyclopropylglycine Recommend Suppliers Recommend You Select Member Compan...
Macklin/麦克林 (S)-2-(叔丁氧羰基)氨基)-2-环丙基乙酸 2-8°C 湿冰 2-8°C 货号: 110973 品牌: Macklin/麦克林 规格: 1g 97% 包装: 1g/瓶 编码: B842386-1g CAS 编码: 155976-13-9 分子式: C10H17NO4 分子量: 215.25 价格:¥ 90.00 / 瓶 ...
Look through Boc-L-cyclopropylglycine MSDS details show. We provide Boc-L-cyclopropylglycine 155976-13-9 safety data sheet view and download for free at Echemi.com.
The derivatives serve as a metabolic-regulation type L-glutamate receptor agonist having a high selectively and excellent characteristics as compared with known ones.TAGUCHI, TAKEOISHIDA, MICHIKOSHINOZAKI, HARUHIKOWO1998000391A1 Dec 27, 1996 Jan 8, 1998 Michiko Ishida Cyclopropylglycine derivatives and ...
N-Chloroacetyl-L-α-cyclopropylglycine 1.2 CAS No. 121786-35-4 1.4 Molecular Formula Co2Fe2O5 1.5 Inchi InChI=1S/2Co.2Fe.5O/q2*+2;2*+3;5*-2 1.6 InChkey XNGOCNMGDFPQTP-UHFFFAOYSA-N 1.7 Canonical Smiles [O--].[O--].[O--].[O--].[O--].[Fe+3].[Fe+3].[Co++].[Co...
CYCLOPROPYLGLYCINE DERIVATIVE AND METABOLIC REGULATION TYPE L-GLUTAMIC ACID RECEPTOR AGONISTPROBLEM TO BE SOLVED: To obtain the subject derivative more selective than a metabolic regulation type L-glutamic acid receptor agonist, exhibiting excellent characteristics, useful for treating Huntington's disease, ...
Cyclopropylglycine derivatives and agonists for metabotronic L-glutamate receptorsA cyclopropylglycine derivative having the following formuladoi:US6245919 B1Haruhiko ShinozakiTakeo TaguchiMichiko IshidaUS
CYCLOPROPYLGLYCINE DERIVATIVE AND METABOLIC REGULATION TYPE L-GLUTAMIC ACID RECEPTOR AGONISTPROBLEM TO BE SOLVED: To obtain the subject derivative more selective than a metabolic regulation type L-glutamic acid receptor agonist, exhibiting excellent characteristics, useful for treating Huntington's disease, ...